Advertisement

Topics

Deal Watch: BioCryst Shareholder Dissent Scuttles Planned Merger With Idera

13:44 EDT 13 Jul 2018 | SCRIP

AZ’s MedImmune to use 4D’s AAV vector technology to deliver therapies for chronic lung disease, while Roivant spinout Dermavant licenses...

      

Related Stories

 

Original Article: Deal Watch: BioCryst Shareholder Dissent Scuttles Planned Merger With Idera

NEXT ARTICLE

More From BioPortfolio on "Deal Watch: BioCryst Shareholder Dissent Scuttles Planned Merger With Idera"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...